Drug Shortage Report for PRIMENE 10%

Last updated on 2023-10-16 History
Report ID 190244
Drug Identification Number 02236875
Brand name PRIMENE 10%
Common or Proper name Amino Acid Injection 10% w/v
Company Name BAXTER CORPORATION
Market Status MARKETED
Active Ingredient(s) L-ORNITHINE DIHYDROCHLORIDE L-PROLINE GLYCINE SERINE L-ASPARTIC ACID L-ALANINE L-ARGININE GLUTAMIC ACID L-TYROSINE TAURINE TRYPTOPHAN METHIONINE L-CYSTEINE L-THREONINE HISTIDINE L-PHENYLALANINE L-ISOLEUCINE L-VALINE L-LYSINE L-LEUCINE
Strength(s) 318MG 300MG 400MG 400MG 600MG 800MG 840MG 1G 45MG 60MG 200MG 240MG 189MG 370MG 380MG 420MG 670MG 760MG 1.1G 1G
Dosage form(s) LIQUID
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 250mL
ATC code B05BA
ATC description I.V. SOLUTIONS
Reason for shortage Shortage of an inactive ingredient or component.
Anticipated start date 2023-04-24
Actual start date 2023-04-24
Estimated end date 2023-08-15
Actual end date 2023-08-15
Shortage status Resolved
Updated date 2023-10-16
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 7125 MISSISSAUGA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 0C2
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v12 2023-10-16 English Compare
v11 2023-08-16 English Compare
v10 2023-08-15 French Compare
v9 2023-08-15 English Compare
v8 2023-08-04 French Compare
v7 2023-08-04 English Compare
v6 2023-08-04 English Compare
v5 2023-08-04 English Compare
v4 2023-05-16 English Compare
v3 2023-04-25 English Compare
v2 2023-04-24 French Compare
v1 2023-04-24 English Compare

Showing 1 to 12 of 12